Search Results 321-330 of 17136 for Birth Control Evolution

1. Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus with Ultrasound and Systemic Tissue Plasminogen Activator (tPA) for Emergent Revascularization in Acute Ischemic Stroke - Mayo Clinic

   Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus with Ultrasound and Systemic Tissue Plasminogen Activator (tPA) ...

2. A Study to Improve Diabetes Management Among Adults Experiencing Severe Hypoglycemia - Mayo Clinic

   ... Management), a comprehensive community paramedic (CP) program to improve diabetes self-management among adults in Southeast Minnesota (SEMN) treated for ...

3. Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer - Mayo Clinic

   to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to the study, for the duration of study participation, and 6 ...

4. Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery - Mayo Clinic

   Participant agrees to use acceptable form of contraception during the study and for up to 7 months after last study drug dose ... pills (i.e. "Mini-pill"); Tubal ...

5. A Study to Evaluate Preoperative Oral Microbiota-Based Investigational New Drug to Target Immune Response in Patients with Operable Stage I-III Breast Cancer - Mayo Clinic

   Note: Adequate contraception methods include birth control pills, barrier device, intrauterine device. Capable of understanding the investigative nature ...

6. A Study to Evaluate CB-839 With Radiation Therapy and Temozolomide in Treating Participants With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma - Mayo Clinic

   ... contraception (hormonal or barrier method of birth control; abstinence) prior to study entry and for the duration of study participation. Should a woman ...

7. Medical Research & Education - Mayo Clinic News Network

   August 2, 2023. 2023 Gerstner Awardee's 'evolutionary therapy' targets pancreatic cancer treatment resistance featured image. Research. 2023 Gerstner Awardee's ...

8. A Study to Measure Markers of Immune Tolerance to Predict Women at Risk of Miscarriage or Failed Embryo Transfer - Mayo Clinic

   ... birth or no live birth. Spontaneous Conception Cohort - To determine if maternal blood concentrations of Gal-9, IL-4, and VEGF-A, -C, -D early in the first ...

9. Medical Research & Education - Mayo Clinic News Network

   Latest stories · Corticosteroids lower the likelihood of in-hospital mortality from COVID-19 featured image · 2023 Gerstner Awardee's 'evolutionary therapy' ...

10. Medical Research & Education - Mayo Clinic News Network

    How contact tracing has evolved and ways to get through the next COVID-19 wave. DeeDee Stiepan. November 2, 2020. Biotherapeutics.